Can Quantum Computing’s Government Contracts Boost Future Growth?
Quantum Computing Inc. or “QCi” QUBT is continuously focused on strengthening its engagement with strategic government partners. During…
Can FUTU’s Wealth Management Take Off?
Futu Holdings Limited FUTU reported a record year-over-year client asset surge of 68.1% and a sequential 17.4% rise…
Quantum Computing Expands Global Reach With New Research Collabs
Quantum Computing Inc. QUBT or QCi continues to gain traction among key academic and research partners worldwide. Recently,…
Dropbox, Crexendo Remain Our Top Picks in Internet Services
Macro factors currently driving the economy, such as inflation, interest rates, labor markets, supply chain issues and so…
Which Quantum Computing Stock Is the Smarter Buy?
Quantum computing is moving from lab prototypes to commercial pathways, and for investors, two pure-play names, Rigetti Computing…
ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression
AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…
Will Chiplets Give Rigetti the Edge in the Race to Quantum Scale?
Rigetti Computing RGTI is leaning heavily on chiplets as the way to make quantum computers truly scalable. In…
Can Oklo’s Fuel Recycling Strategy Change Nuclear Power?
Oklo Inc. OKLO is rethinking how nuclear energy is produced, and at the center of its strategy is…
Which Quantum Stock Is a Smarter Bet?
Quantum computing is no longer just a scientific experiment; it is shaping up to be the next frontier…
Howmet’s Transportation Market Shrinks: What’s the Path Forward?
Howmet Aerospace Inc. HWM is facing continued softness in its commercial transportation market. In first-quarter of 2025, revenues…
EPD Advances Backlog of Growth Projects: Will This Boost Margins?
Enterprise Products Partners EPD is rapidly advancing its $7.6-billion capital project slate, with $6 billion in assets expected to enter…
FDA Rejects CAPR’s Cell Therapy BLA for Genetic Disorder, Stock Tanks
Shares of Capricor Therapeutics CAPR tanked 33% on Friday after it announced that the FDA issued a complete…